These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 38088673)
1. Sialic acid as the potential link between lipid metabolism and inflammation in the pathogenesis of atherosclerosis. Poznyak AV; Kashirskikh DA; Postnov AY; Popov MA; Sukhorukov VN; Orekhov AN Braz J Med Biol Res; 2023; 56():e12972. PubMed ID: 38088673 [TBL] [Abstract][Full Text] [Related]
2. The role of sialic acids in the initiation of atherosclerosis. Poznyak AV; Zhang D; Grechko AV; Wu WK; Orekhov AN Minerva Cardioangiol; 2020 Aug; 68(4):359-364. PubMed ID: 32472985 [TBL] [Abstract][Full Text] [Related]
3. Sialic acid metabolism as a potential therapeutic target of atherosclerosis. Zhang C; Chen J; Liu Y; Xu D Lipids Health Dis; 2019 Sep; 18(1):173. PubMed ID: 31521172 [TBL] [Abstract][Full Text] [Related]
4. Sialic acid content of LDL in coronary artery disease: no evidence of desialylation in subjects with coronary stenosis and increased levels in subjects with extensive atherosclerosis and acute myocardial infarction: relation between desialylation and in vitro peroxidation. Chappey B; Beyssen B; Foos E; Ledru F; Guermonprez JL; Gaux JC; Myara I Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):876-83. PubMed ID: 9633926 [TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification. Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784 [TBL] [Abstract][Full Text] [Related]
9. Possible involvement of radical reactions in desialylation of LDL. Tanaka K; Tokumaru S; Kojo S FEBS Lett; 1997 Aug; 413(2):202-4. PubMed ID: 9280282 [TBL] [Abstract][Full Text] [Related]
10. The sialylation of plasma lipoproteins. Millar JS Atherosclerosis; 2001 Jan; 154(1):1-13. PubMed ID: 11137077 [TBL] [Abstract][Full Text] [Related]
11. Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis. Poznyak AV; Kashirskikh DA; Sukhorukov VN; Kalmykov V; Omelchenko AV; Orekhov AN Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163256 [TBL] [Abstract][Full Text] [Related]
12. Biochemical and structural basis of sialic acid utilization by gut microbes. Bell A; Severi E; Owen CD; Latousakis D; Juge N J Biol Chem; 2023 Mar; 299(3):102989. PubMed ID: 36758803 [TBL] [Abstract][Full Text] [Related]
13. The role of mitochondria in cardiovascular diseases related to atherosclerosis. Glanz VY; Sobenin IA; Grechko AV; Yet SF; Orekhov AN Front Biosci (Elite Ed); 2020 Jan; 12(1):102-112. PubMed ID: 31585872 [TBL] [Abstract][Full Text] [Related]
14. Resialylation of sialic acid deficit vascular endothelium, circulating cells and macromolecules may counteract the development of atherosclerosis: a hypothesis. Lindberg G Atherosclerosis; 2007 Jun; 192(2):243-5. PubMed ID: 17420020 [TBL] [Abstract][Full Text] [Related]
15. Human species-specific loss of CMP- Kawanishi K; Dhar C; Do R; Varki N; Gordts PLSM; Varki A Proc Natl Acad Sci U S A; 2019 Aug; 116(32):16036-16045. PubMed ID: 31332008 [TBL] [Abstract][Full Text] [Related]
16. Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD. Poznyak AV; Bharadwaj D; Prasad G; Grechko AV; Sazonova MA; Orekhov AN Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206708 [TBL] [Abstract][Full Text] [Related]
17. A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells. Libby P; Alroy J; Pereira ME J Clin Invest; 1986 Jan; 77(1):127-35. PubMed ID: 3080470 [TBL] [Abstract][Full Text] [Related]
18. Sialic acid diversity in the human gut: Molecular impacts and tools for future discovery. Sokolovskaya OM; Tan MW; Wolan DW Curr Opin Struct Biol; 2022 Aug; 75():102397. PubMed ID: 35653953 [TBL] [Abstract][Full Text] [Related]